Global Infusion Therapy Market Size Likely to Expand at a CAGR of 10.6% By 2034

Global Infusion Therapy Market size was valued at USD 38,926.03 Million in 2025 and is expected to reach USD 96,390.96 Million by 2034 at a CAGR of 10.6% during the forecast period 2025 – 2034.

Infusion Therapy Market Overview

Infusion therapy is used to treat medical conditions, such as infections and diseases, which do not respond to oral antibiotics. An infusion therapy provider specializes in giving infusion treatment to patients in their homes or other alternative settings.

Extensive service, prescription drugs, and biologics can be administered safely and effectively at patients’ homes or other places. Due to contact with contaminated equipment, bedclothes, and aircraft, there is an increase in hospital-deficit infections due to promoting market development.

In addition, the demand for home infusion therapy is increasing to reduce the possibility of infection and ensure the best possible care. The development of user-friendly home infusion kit is another factor driving the development of the industry.

The driver of the infusion therapy market is a growing demand for home infusion therapy, which helps reduce hospitalizations and reduce the risk of hospital infection (HAIS). In addition, the increasing number of patients requiring chronic disease management, mainly for cancer, heart disease, and diabetes, contributes to the growth of the market.

Technological development in wearable infusion pumps and telemedicine is increasing distant patient monitoring, improving the effectiveness of home infusion therapy. On the other hand, the market faced a lack of reimbursement for home care in many countries, especially in emerging markets like India and China, where out-of-pocket healthcare expenses are high due to the market.

Market development opportunities lie in addressing chronic diseases, especially cancer, which is one of the major causes of death globally. As the occurrence of cancer and other chronic conditions increases, the demand for constant and accurate infusion treatments increases. Also, progress in infusion technology, such as smart infusion pumps and the development of wearable equipment, provides new solutions for patient care mainly for those undergoing treatment at home.

The infusion therapy market is segmented into various product categories such as infusion pumps, intravenous sets, IV cannulas, and sureless connectors. The infusion pump section currently dominates the market, due to its versatility and suitability for a wide range of treatments, especially in chemotherapy and diabetes management.

Infusion pumps are likely to maintain their dominance in the infusion therapy market due to their ability to provide accurate and controlled drug distribution, which increases patient treatment results. For example, insulin-dependent diabetes patients rely on infusion pumps for constant glucose management.

In terms of the performance of the regional market, North America currently leads the infusion medical market and is expected to maintain this condition during the forecast period. It is inspired by a high demand for infusion remedies in the dominant region, which is inspired by the increasing senior population and increasing proliferation of chronic diseases such as cancer, diabetes, and heart disease.

The players in the infusion therapy market are constantly innovating to meet the growing demand. For instance, in 2024, Brightstar Care Company, in collaboration with Paragon Healthcare, provided quality infusion therapy in the US. These developments indicate the growing trend towards innovation in infusion therapy, further driving market growth.

Report Scope

CMI has comprehensively analyzed the Global Infusion therapy market. The drivers, restraints, challenges, opportunities, and key trends have been explained in depth to depict an in-depth scenario of the Infusion therapy market. Segment wise market size and market share for Infusion therapy during the forecast period are duly addressed to portray the probable picture of the Global Infusion therapy industry.

The competitive landscape includes key innovators, market giants as well and niche players are studied and analyzed extensively concerning their strengths, weaknesses as well as value addition prospects. In addition, the report covers Infusion therapy key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.

List of the prominent players in the Infusion Therapy Market:

• Braun Melsungen AG
• Abbott Laboratories
• Fresenius Kabi AG
• Baxter
• Care Fusion Corporation
• Hospira Inc.
• AccuVein
• Stryker Corporation
• Vuetek Scientific
• Smiths Medical
• IV-EYE
• Veinlite
• Aetna
• Continuum Rx
• Evena
• Carecentrix
• Bristol-Myers Squibb
• Axela Care
• Tricare
• Eli Lilly and Company
• Others

The Infusion Therapy Market is segmented as follows:

By Product

• Infusion Pump
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

By Application

• Anti-infective
• Hydration Therapy
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Other

By End-user

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Homecare Settings

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America